Evidence map›Paper›PMID 39013652›Full record

ArticleBMJ open2024

Access to and utilisation of antimicrobials among forcibly displaced persons in Uganda, Yemen and Colombia: a pilot cross-sectional survey.

David Kamiab Hesari, Saleh Aljadeeah, Petra Brhlikova, Dalia Hyzam, Henry Komakech, Jhon Sebastián Patiño Rueda, Jovana Ocampo Cañas, Carly Ching, Samuel Orubu, Oscar Bernal Acevedo and 4 more

Abstract read
In one paragraph

Article in BMJ open, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

David Kamiab HesariInstitute for Medical Microbiology, Immunology and Hygiene, Technical University of Munich, Munich, Germany.ORCID 0000-0002-2953-3252
Saleh AljadeeahDepartment of Public Health, Institute of Tropical Medicine, Antwerpen, Belgium.ORCID 0000-0003-4035-4121
Petra BrhlikovaInstitute for Health and Society, Newcastle University, Newcastle upon Tyne, UK.ORCID 0000-0003-2085-0304
Dalia HyzamWomen's Research and Training Centre, University of Aden, Aden, Yemen.ORCID 0000-0001-9960-096X
Henry KomakechDepartment of Community Health and Behavioral Science, Makerere University School of Public Health, Kampala, Uganda.
Jhon Sebastián Patiño RuedaUniversidad de los Andes Facultad de Medicina, Bogota, Colombia.
Jovana Ocampo CañasUniversidad de los Andes Facultad de Medicina, Bogota, Colombia.
Carly ChingDepartment of Biomedical Engineering, Boston University, Boston, Massachusetts, USA.ORCID 0000-0002-6785-636X
Samuel OrubuInstitute for Health System Innovation and Policy, Boston University, Boston, Massachusetts, USA.
Oscar Bernal AcevedoUniversidad de los Andes, Bogota, Colombia.
Huda BasaleemFaculty of Medicine and Health Sciences, University of Aden, Aden, Yemen.
Christopher Garimoi OrachMakerere University College of Health Sciences, Kampala, Uganda.
Muhammad ZamanDepartment of Biomedical Engineering, Boston University, Boston, Massachusetts, USA.
Clarissa Prazeres da CostaInstitute for Medical Microbiology, Immunology and Hygiene, Technical University of Munich, Munich, Germany Clarissa.daCosta@tum.de.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectivesIdentifying key barriers to accessing quality-assured and affordable antimicrobials among forcibly displaced persons in Uganda, Yemen and Colombia and investigating their (1) utilisation patterns of antibiotics, (2) knowledge about antimicrobial resistance (AMR) and (3) perception of the quality of antimicrobials received.

designPilot cross-sectional survey.

settingData were collected from five health facilities in the Kiryandongo refugee settlement (Bweyale, Uganda), three camps for internally displaced persons (IDPs) in the Dar Sad district (Aden, Yemen) and a district with a high population of Venezuelan migrants (Kennedy district, Bogotá, Colombia). Data collection took place between February and May 2021. The three countries were selected due to their high number of displaced people in their respective continents.

participantsSouth Sudanese refugees in Uganda, IDPs in Yemen and Venezuelan migrants in Colombia. OUTCOME MEASURE: The most common barriers to access to quality-assured and affordable antimicrobials.

resultsA total of 136 participants were enrolled in this study. Obtaining antimicrobials through informal pathways, either without a doctor's prescription or through family and friends, was common in Yemen (27/50, 54.0%) and Colombia (34/50, 68.0%). In Yemen and Uganda, respondents used antibiotics to treat (58/86, 67.4%) and prevent (39/86, 45.3%) a cold. Knowledge of AMR was generally low (24/136, 17.6%). Barriers to access included financial constraints in Colombia and Uganda, prescription requirements in Yemen and Colombia, and non-availability of drugs in Uganda and Yemen.

conclusionOur multicentred research identified common barriers to accessing quality antimicrobials among refugees/IDPs/migrants and common use of informal pathways. The results suggest that knowledge gaps about AMR may lead to potential misuse of antimicrobials. Due to the study's small sample size and use of non-probability sampling, the results should be interpreted with caution, and larger-scale assessments on this topic are needed. Future interventions designed for similar humanitarian settings should consider the interlinked barriers identified.

Indexed as

Health Services AccessibilityRefugeesAdolescentAdultAnti-Bacterial AgentsAnti-Infective AgentsColombiaCross-Sectional StudiesFemaleHealth Knowledge, Attitudes, PracticeHumansMaleMiddle AgedPilot ProjectsUgandaYemenAnti-Bacterial AgentsAnti-Infective AgentsCross-Sectional StudiesHealth Services AccessibilityINFECTIOUS DISEASESMICROBIOLOGYPharmacologyPUBLIC HEALTH

Identifiers

PMID39013652
PMCPMC11253744

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.